NCT00064116 - Combination Chemotherapy With or Without Rituximab in Non-Hodgkin's Lymphoma | Biotech Hunter

Enrollment

824

Participants

Timeline

Start Date

May 8, 2001

Primary Completion Date

December 31, 2010

Study Completion Date

January 16, 2014

Conditions

Lymphoma

Interventions

BIOLOGICAL

rituximab

Rituximab 375 mg/m² i.v. day 1

DRUG

CHOP regimen

Cyclophosphamide 750 mg/m² i.v. day 1 Doxorubicin 50 mg/m² i.v. day 1 Vincristine 2 mg (abs.) i.v. day 1 Prednisone 100 mg/d p.o. days 1 to 5 Recycle day 22 Total number of cycles: 6

Trial Locations (25)

T2N 4N2

Tom Baker Cancer Centre, Calgary

T6G 1Z2

Cross Cancer Institute, Edmonton

R3E 0V9

CancerCare Manitoba, Winnipeg

E1C 6Z8

The Moncton Hospital, Moncton

AIB 3V6

Dr. H. Bliss Murphy Cancer Centre, St. John's

B3H 1V7

QEII Health Sciences Center, Halifax

K7L 5P9

Cancer Centre of Southeastern Ontario at Kingston, Kingston

N2G 1G3

Grand River Regional Cancer Centre, Kitchener

N6A 4L6

London Regional Cancer Program, London

K1H 8L6

Ottawa Health Research Institute - General Division, Ottawa

L2R 7C6

Niagara Health System, St. Catharines

M4N 3M5

Odette Cancer Centre, Toronto

M5G 2C4

Univ. Health Network-The Toronto General Hospital, Toronto

M5G 2M9

Univ. Health Network-Princess Margaret Hospital, Toronto

M9C 1A5

Trillium Health Centre - West Toronto, Toronto

C1A 8T5

PEI Cancer Treatment Centre,Queen Elizabeth Hospital, Charlottetown

J4V 2H1

Hopital Charles LeMoyne, Greenfield Park

H1T 2M4

Hopital Maisonneuve-Rosemont, Montreal

H2L 4M1

CHUM - Hopital Notre-Dame, Montreal

H2W 1S6

McGill University - Dept. Oncology, Montreal

H4J 1C5

Hopital du Sacre-Coeur de Montreal, Montreal

G1S 4L8

CHA-Hopital Du St-Sacrement, Québec

J1H 5N4

Centre hospitalier universitaire de Sherbrooke, Sherbrooke

S4T 7T1

Allan Blair Cancer Centre, Regina

S7N 4H4

Saskatoon Cancer Centre, Saskatoon